CON vs RDNT vs USPH Stock Comparison

Concentra Group Holdings Parent, RadNet and U S Physical Therapy Prices as of Oct 23, 2026 Peers: Industry group
RDNT RadNet, Inc.
$70.34 -3.9% 1M -15.1% 1Y
Market cap
$5.45B
P/E
–
Revenue (TTM)
$2.27B
Div. yield
–
Healthcare Services Healthcare
3 wins

Head to Head

11 decided of 12

Concentra Group Holdings Parent leads on 6 of the 12 questions below (Concentra Group Holdings Parent 6, RadNet 3, U S Physical Therapy 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCONRDNTUSPHLeader
Larger companyMarket capitalisation $5.03B $5.45B $1.34B RDNT
Cheaper on earningsLower P/E, profitable companies only 25.3x -258.2x 41.5x CON
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.8x 132.7x 29.9x CON
Faster revenue growthRevenue growth, trailing twelve months +14.0% +18.9% +11.3% RDNT
More profitableNet margin, trailing twelve months 8.7% -0.9% 4.0% CON
Better return on capitalReturn on invested capital 14.2% 1.5% 9.3% CON
Less leveragedLower net debt / EBITDA 3.1x 2.5x 1.5x USPH
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +91.2% -15.1% -3.0% CON
Better 5-year returnAnnualised price return, 5 years — +17.4%/yr -3.6%/yr RDNT
Less volatileAnnualised volatility, 1 year 27.8% 42.1% 40.2% CON
Higher overall scoreMean of the five percentile scores vs peers 57/100 39/100 59/100 USPH

Percentile Scorecard

CONRDNTUSPH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCONRDNTUSPH
Valuation 59 #39 of 93 40 #56 of 93 76 #23 of 93
Growth 64 #32 of 88 22 #69 of 88 29 #63 of 88
Profitability 86 #13 of 87 45 #48 of 87 61 #35 of 87
Financial Health 27 #73 of 100 43 #57 of 100 48 #53 of 100
Shareholder Returns 51 #28 of 56 42 #33 of 56 84 #10 of 56
Overall 57 39 59
  • CON ranked among 103 companies in Healthcare Providers
  • RDNT ranked among 103 companies in Healthcare Providers
  • USPH ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCONRDNTUSPHSPY
1 month +12.9%-3.9%+7.0% -1.0%
3 months +24.3%+14.2%+18.5% +2.9%
6 months +72.2%+22.1%+20.4% +6.4%
Year to date +99.6%-1.4%+13.4% +11.4%
1 year +91.2%-15.1%-3.0% +13.1%
3 years —+150.0%+2.3% +79.4%
3 years, per year —+35.7%+0.8% +21.5%
5 years —+123.0%-16.5% +67.7%
5 years, per year —+17.4%-3.6% +10.9%
10 years —+794.9%+44.4% +255.2%
10 years, per year —+24.5%+3.7% +13.5%

Risk

MeasureCONRDNTUSPHSPY
Volatility, 1Y 27.8%42.1%40.2% 12.7%
Downside volatility, 1Y 23.1%42.5%45.4% 12.7%
Beta vs S&P 500, 1Y 0.411.000.61 1.00
Return / volatility, 1Y 3.28-0.36-0.08 1.03
Max drawdown, 5Y -23.5%-56.2%-54.7% -25.4%
From 52-week high -1.7%-16.7%-4.9% -2.5%
52-week high $39.97$84.48$93.16 $779.14
52-week low $18.71$51.87$59.00 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCONRDNTUSPH
P/E now vs peer median 24.7xmedian 25.3x -259.1xmedian 25.3x 41.4xmedian 25.3x
P/S now vs peer median 2.2xmedian 1.6x 2.4xmedian 1.6x 1.6xmedian 1.6x
EV/EBITDA now vs peer median 14.0xmedian 14.6x 25.2xmedian 14.6x 14.8xmedian 14.6x
P/FCF now vs peer median 18.7xmedian 22.7x -16.0xmedian 22.7x 20.6xmedian 22.7x
P/B now vs peer median 10.3xmedian 3.3x 4.0xmedian 3.3x 2.9xmedian 3.3x
PEG now vs peer median —median 0.66 31.65median 0.66 -32.44median 0.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCONRDNTUSPH
Revenue $2.29B $2.27B $812.20M
Gross profit $670.56M $261.62M $151.70M
Operating income $374.81M $70.78M $76.52M
Net income $203.80M $80.00K $49.87M
Free cash flow $267.42M -$344.77M $64.07M
EPS (diluted) $1.56 $-0.27 $2.14
Cash & equivalents $158.04M $726.27M $24.89M
Total debt $1.57B $4.61B $173.13M
Shares (diluted) 127.79M 78.73M 15.07M
Enterprise value $4.68B $2.70B $1.22B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCONRDNTUSPH
P/E 24.7x -259.1x 41.4x
P/FCF 18.7x -16.0x 20.6x
P/Operating cash flow 14.9x 17.8x 15.9x
P/S 2.2x 2.4x 1.6x
P/B 10.3x 4.0x 2.9x
P/Tangible book 19.8x 4.8x 4.8x
EV/EBITDA 14.0x 25.2x 14.8x
EV/EBIT 17.1x 86.7x 19.2x
EV/Revenue 2.8x 2.7x 1.8x
EV/FCF 24.0x -17.8x 22.9x
EV/Operating cash flow 19.2x 19.8x 17.7x
PEG (3Y EPS CAGR) – 31.65 -32.44

Growth

14 metrics
MetricCONRDNTUSPH
Revenue growth (1Y) 14.0% 18.9% 11.3%
Revenue CAGR (3Y) – 14.1% 11.8%
Gross profit growth (1Y) 18.9% 17.8% 12.9%
Gross profit CAGR (3Y) – 11.7% 8.8%
Operating income growth (1Y) 18.9% 8.5% -0.7%
Operating income CAGR (3Y) – 5.9% 9.2%
Net income growth (1Y) 32.6% -99.3% -6.7%
Net income CAGR (3Y) – -74.7% 5.5%
EPS growth (1Y) 33.5% -35.8% -14.8%
EPS CAGR (3Y) – -8.2% -1.3%
Operating cash flow growth (1Y) 29.2% 18.5% 15.8%
Operating cash flow CAGR (3Y) – 19.6% 6.0%
Free cash flow growth (1Y) 43.1% -1,140% 5.3%
Free cash flow CAGR (3Y) – -66.2% 1.3%

Profitability

14 metrics
MetricCONRDNTUSPH
Gross margin 29.3% 11.5% 18.7%
EBITDA margin 20.0% 10.7% 12.2%
Operating margin 16.4% 3.1% 9.4%
Pretax margin 11.7% 1.5% 8.3%
Net margin 8.7% -0.9% 4.0%
FCF margin 11.7% -15.2% 7.9%
Operating cash flow margin 14.7% 13.7% 10.2%
Return on equity 44.8% 1.4% 10.9%
Return on assets 7.0% 0.5% 4.0%
Return on invested capital 14.2% 1.5% 9.3%
Return on capital employed 14.5% 2.1% 6.7%
Asset turnover 0.8x 0.6x 0.7x
Cash conversion (OCF / net income) 1.6x 3,876x 1.7x
Stock comp / revenue 0.6% 2.6% 1.1%

Financial Health

11 metrics
MetricCONRDNTUSPH
Debt / assets 52.3% 31.5% 13.9%
Debt / equity 3.2x 1.0x 0.4x
Net debt / EBITDA 3.1x 2.5x 1.5x
Debt / FCF 5.9x -3.9x 2.7x
Liabilities / assets 83.9% 67.0% 64.0%
Equity / assets 16.1% 33.0% 36.0%
Interest coverage – 1.0x 7.1x
Current ratio 1.4x 1.5x 1.3x
Quick ratio 1.2x 1.4x 0.9x
Cash ratio 0.4x 1.0x 0.2x
Altman Z-score 2.53 1.82 2.11

Shareholder Returns

7 metrics
MetricCONRDNTUSPH
Dividend yield 0.6% – 2.1%
Net buyback yield 0.5% -0.1% –
Shareholder yield 1.1% -0.1% 2.1%
Payout ratio (earnings) 15.7% – –
Payout ratio (FCF) 12.0% – –
Dividend growth (1Y) 33.4% – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCONRDNTUSPH
Forward P/E 22.8xFY2026 132.7xFY2026 29.9xFY2026
EPS, next fiscal year $1.72FY2026 $0.53FY2026 $2.96FY2026
EPS growth, next FY +25.5%FY2026 +35.9%FY2026 +12.5%FY2026
EPS growth, the year after +10.5% +71.7% +8.4%
Revenue, next fiscal year $2.30BFY2026 $2.68BFY2026 $799.07MFY2026
Revenue growth, next FY +6.3%FY2026 +31.4%FY2026 +2.3%FY2026
Revenue growth, the year after +2.7% -1.2% +10.3%
CON estimates →RDNT estimates →USPH estimates →

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCONRDNTUSPH
Held by institutions 87.3% 100.0% 100.0%
Institutions holding 291 328 217
Change in shares held, QoQ +4.0% +6.0% +0.8%
Institutions buying 166 175 98
Institutions selling 81 110 90
Buyers to sellers 2.05 1.59 1.09
CON holders →RDNT holders →USPH holders →

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CONRDNTUSPH
CON 1.00 0.24 0.24
RDNT 0.24 1.00 0.24
USPH 0.24 0.24 1.00

Add a Peer

Largest companies in the same industry
CON · Healthcare Services
+FMSFresenius Medical Care AG +DVADavita +LFSTLifeStance Health +SGRYSurgery Partners +PRVAPrivia Health +MDPediatrix Medical +PGNYProgyny +STLNStarling Oncology
Plot all 84 Healthcare Services stocks →

Related Comparisons

CON vs FMSFresenius Medical Care AG CON vs DVADavita CON vs LFSTLifeStance Health CON vs SGRYSurgery Partners

Frequently Asked Questions

Which is bigger, CON, RDNT and USPH?

RadNet (RDNT) is the largest by market capitalisation: Concentra Group Holdings Parent (CON) $5.03B, RadNet (RDNT) $5.45B, U S Physical Therapy (USPH) $1.34B.

Which stock is cheaper, CON, RDNT and USPH?

Concentra Group Holdings Parent (CON) trades on the lowest price-to-earnings ratio (Concentra Group Holdings Parent (CON) 25.3x, RadNet (RDNT) -258.2x, U S Physical Therapy (USPH) 41.5x). On next year's consensus earnings, Concentra Group Holdings Parent (CON) is cheapest (Concentra Group Holdings Parent (CON) 22.8x, RadNet (RDNT) 132.7x, U S Physical Therapy (USPH) 29.9x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

RadNet (RDNT) grew revenue fastest over the trailing twelve months: Concentra Group Holdings Parent (CON) +14.0%, RadNet (RDNT) +18.9%, U S Physical Therapy (USPH) +11.3%.

Which company is more profitable?

Concentra Group Holdings Parent (CON) has the highest net margin (Concentra Group Holdings Parent (CON) 8.7%, RadNet (RDNT) -0.9%, U S Physical Therapy (USPH) 4.0%). On return on invested capital, Concentra Group Holdings Parent (CON) leads (Concentra Group Holdings Parent (CON) 14.2%, RadNet (RDNT) 1.5%, U S Physical Therapy (USPH) 9.3%).

Which stock has performed better?

Over the past year Concentra Group Holdings Parent (CON) returned the most: Concentra Group Holdings Parent (CON) +91.2%, RadNet (RDNT) -15.1%, U S Physical Therapy (USPH) -3.0%. Over five years, RadNet (RDNT) compounded fastest (RadNet (RDNT) +17.4%/yr, U S Physical Therapy (USPH) -3.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Concentra Group Holdings Parent (CON) 0.01%, RadNet (RDNT) 0.00%, U S Physical Therapy (USPH) 0.00%. RadNet (RDNT) and U S Physical Therapy (USPH) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Concentra Group Holdings Parent (CON) has been the steadiest (Concentra Group Holdings Parent (CON) 27.8%, RadNet (RDNT) 42.1%, U S Physical Therapy (USPH) 40.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CON, RDNT and USPH?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Concentra Group Holdings Parent (CON) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.